Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Satoshi Noto"'
Autor:
Setsuko Oyama, Tatsuya Shirai, Yukiko Abe, Maya Tsuchiya, Toshiya Inui, Kozo Suhara, Satoshi Noto, Mitsuhiro Kamimura
Publikováno v:
Respirology Case Reports, Vol 11, Iss 4, Pp n/a-n/a (2023)
Key message Hemophagocytic lymphohistiocytosis (HLH) has been reported as a rare complication of immune checkpoint inhibitors (ICI); however, ICI‐related HLH is a life‐threatening and comparatively late adverse event. Early diagnosis is critical,
Externí odkaz:
https://doaj.org/article/8ff09e62b1694333832c197f3eaf80af
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e219-e220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::283d85b1407c9a82f2db011f0a8d1d2e
https://doi.org/10.1016/j.clml.2019.09.365
https://doi.org/10.1016/j.clml.2019.09.365
Publikováno v:
International Journal of Hematology. 101:268-272
Immune thrombocytopenic purpura (ITP) is an acquired disorder characterized by thrombocytopenia, increased platelet destruction, and the inhibition of platelet production by specific autoantibodies. Previous studies have reported improvements in ITP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3645a33e578c500d33630925427913f
https://doi.org/10.1007/s12185-015-1737-9
https://doi.org/10.1007/s12185-015-1737-9
Autor:
Kaori Ootsubo, Akihisa Nagata, Kiyoe Midorikawa, Kazuaki Yamada, Naohiro Sekiguchi, Naoki Takezako, Miyuki Wagatsuma, Satoshi Noto
Publikováno v:
International Journal of Hematology. 99:288-295
Recent studies have suggested that c-Myc over-expression may be a factor indicating poor prognosis in multiple myeloma (MM), although c-Myc gene-related abnormalities, including translocation and gene amplification, have not been fully investigated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d42559637e66f3921caebdf0755340
https://doi.org/10.1007/s12185-014-1514-1
https://doi.org/10.1007/s12185-014-1514-1
Autor:
Kenichi Ito, Satoshi Noto, Naoya Kaneko, Naoki Takezako, Takanori Teshima, Naohiro Sekiguchi, Airi Hamano
Publikováno v:
Blood. 134:5595-5595
Background Although multiple myeloma remains an incurable disease, the triplet therapy with novel agents has significantly improved the prognosis. However, the utility of the novel agents is often not obtained in transplant-ineligible patients, parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::660341ce3f11135b13a6cc0422f73460
https://doi.org/10.1182/blood-2019-131617
https://doi.org/10.1182/blood-2019-131617
Autor:
Akiyoshi Miwa, Takashi Ishii, Satoshi Noto, Akihisa Nagata, Naohiro Sekiguchi, Naoki Takezako
Publikováno v:
International Journal of Clinical Medicine. :52-57
Recently, mixed phenotype acute leukemia (MPAL) with t (9; 22) (q34; q11.2); bcr-abl1 was described as one kind of acute leukemia of ambiguous lineage in the 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e038f8f9a6450527022de549f391925
https://doi.org/10.4236/ijcm.2013.41011
https://doi.org/10.4236/ijcm.2013.41011
Autor:
Naohiro Sekiguchi, Ichiro Fukuda, Kiyoe Midorikawa, Ikuo Saito, Kazuaki Yamada, Akiyoshi Miwa, Junya Miyahara, Satoshi Noto, Naoki Takezako, Miyuki Wagatsuma
Publikováno v:
Journal of Cancer Therapy. :448-451
The prognosis of CD20-positive (CD20+) diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) recurrence is still poor. A standard treatment for CD20+ DLBCL with CNS recurrence in elderly patients has not been established mainly due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74e1cb4a654f5205eed686e922c54584
https://doi.org/10.4236/jct.2013.43a054
https://doi.org/10.4236/jct.2013.43a054
Autor:
Shunsuke Tezuka, Naohiro Sekiguchi, Takeshi Hagino, Kiyoe Midorikawa, Ikuo Saito, Akiyoshi Miwa, Satoshi Noto, Miyuki Wagatsuma, Kazuaki Yamada, Naoki Takezako
Publikováno v:
Internal Medicine. 52:2801-2804
Extramedullary hematopoietic effusion (EHE) is recognized to be an unusual phenomenon accompanied by hematologic disorders. Only a few reports are available of EHE occurring in patients with lymphoma. We herein report the case of a 54-year-old man wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce072f4bedf2a11ceee0e02f49de54e1
https://doi.org/10.2169/internalmedicine.52.0244
https://doi.org/10.2169/internalmedicine.52.0244
Autor:
Naohiro Sekiguchi, Masahide Iijima, Miyuki Wagatsuma, Satoshi Noto, Naoki Takezako, Kiyoe Midorikawa, Miwa Kurimoto, Kazuaki Yamada, Akihisa Nagata
Publikováno v:
Internal medicine (Tokyo, Japan). 55(4)
Gamma heavy chain disease (gHCD) is a rare lymphoproliferative disorder characterized by the production of a truncated immunoglobulin heavy chain. Although some cases of gHCD are concurrent with other lymphoid neoplasms, few have been reported. We he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb9931c505b537b5c62a1a36875b537
https://pubmed.ncbi.nlm.nih.gov/26875967
https://pubmed.ncbi.nlm.nih.gov/26875967
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 56(12)
A 90-year-old woman was diagnosed with chronic myeloid leukemia (CML) of the high risk type (Sokal score 1.5), and was administered imatinib (400 mg/day). However, imatinib had to be switched to nilotinib because she suffered persistent vomiting and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6d96b1e8d16e4f8e0c353c8e8616839
https://pubmed.ncbi.nlm.nih.gov/26725357
https://pubmed.ncbi.nlm.nih.gov/26725357